Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel A Ho

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Nanotechnology|August 20, 2024
Bacteria-responsive drug release platform for the local treatment of bacterial vaginosisChuying Feng, Chen Sun, Emmanuel A Ho
Drug Delivery and Translational Research|December 14, 2024
Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disordersSamiullah Khan, Chi-Wai Do, Emmanuel A Ho
Drug Delivery and Translational Research|March 19, 2017
Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytesJijin Gu, Karam Al-Bayati, Emmanuel A Ho
Clinical Pharmacology and Therapeutics|August 15, 2018
Current State of Microbicide DevelopmentYannick L Traore, Yufei Chen, Emmanuel A Ho
Drug Delivery and Translational Research|May 3, 2026
Exploitation of cholesterol-dependent cytolysins for targeted biosensing and therapeutic systemsHenry O Abanum, Ethan Watt, Emmanuel A Ho
Reviews in Medical Virology|August 27, 2015
Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future directionMiral Fumakia, Sidi Yang, Jijin Gu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 10, 2013
Advancements in the field of intravaginal siRNA deliverySidi Yang, Yufei Chen, Roien Ahmadie, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 30, 2017
A new strategy for battling bacterial resistance: Turning potent, non-selective and potentially non-resistance-inducing biocides into selective onesSadegh Ghanbar, Miral Fumakia, Emmanuel A Ho, et al.
Acta Biomaterialia|October 9, 2016
Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug deliverySeungil Kim, Yufei Chen, Emmanuel A Ho, et al.
Scientific Reports|February 6, 2019
Autophagy induction and PDGFR-β knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infectionSidi Yang, Yannick Traore, Celine Jimenez, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Nanotechnology|August 20, 2024
Bacteria-responsive drug release platform for the local treatment of bacterial vaginosisChuying Feng, Chen Sun, Emmanuel A Ho
Drug Delivery and Translational Research|December 14, 2024
Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disordersSamiullah Khan, Chi-Wai Do, Emmanuel A Ho
Drug Delivery and Translational Research|March 19, 2017
Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytesJijin Gu, Karam Al-Bayati, Emmanuel A Ho
Clinical Pharmacology and Therapeutics|August 15, 2018
Current State of Microbicide DevelopmentYannick L Traore, Yufei Chen, Emmanuel A Ho
Drug Delivery and Translational Research|May 3, 2026
Exploitation of cholesterol-dependent cytolysins for targeted biosensing and therapeutic systemsHenry O Abanum, Ethan Watt, Emmanuel A Ho
Reviews in Medical Virology|August 27, 2015
Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future directionMiral Fumakia, Sidi Yang, Jijin Gu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 10, 2013
Advancements in the field of intravaginal siRNA deliverySidi Yang, Yufei Chen, Roien Ahmadie, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 30, 2017
A new strategy for battling bacterial resistance: Turning potent, non-selective and potentially non-resistance-inducing biocides into selective onesSadegh Ghanbar, Miral Fumakia, Emmanuel A Ho, et al.
Acta Biomaterialia|October 9, 2016
Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug deliverySeungil Kim, Yufei Chen, Emmanuel A Ho, et al.
Scientific Reports|February 6, 2019
Autophagy induction and PDGFR-β knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infectionSidi Yang, Yannick Traore, Celine Jimenez, et al.
Pageof 6